Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 18/20 | 0.80 |
| ▸ | JAK2 | O60674 | 16/20 | 0.75 |
| ▸ | JAK1 | P23458 | 13/20 | 0.75 |
| ▸ | TYK2 | P29597 | 15/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12385675 | 1.00 | JAK3 (0.80) | JAK3JAK2JAK1TYK2CYP3A4 | |
| SCHEMBL12385611 | 0.93 | JAK3 (0.73) | JAK3JAK2JAK1TYK2CYP3A4 | |
| SCHEMBL2272902 | 0.93 | JAK3 (0.73) | JAK3JAK2JAK1TYK2CYP3A4 | |
| SCHEMBL22641779 | 0.90 | JAK3 (0.69) | JAK3JAK2JAK1TYK2CYP3A4 | |
| SCHEMBL2276691 | 0.89 | JAK3 (1.00) | JAK3JAK2JAK1TYK2 | |
| SCHEMBL12385677 | 0.89 | JAK3 (1.00) | JAK3JAK2JAK1TYK2 | |
| SCHEMBL12385680 | 0.86 | JAK3 (0.84) | JAK3JAK2JAK1TYK2CYP3A4 | |
| SCHEMBL2224001 | 0.86 | JAK3 (0.84) | JAK3JAK2JAK1TYK2CYP3A4 | |
| SCHEMBL2226290 | 0.86 | JAK1 (1.00) | JAK3JAK2JAK1TYK2 | |
| SCHEMBL2297203 | 0.85 | JAK1 (0.81) | JAK3JAK2JAK1TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020200291-A1 | COMPOUNDS AND METHODS OF TREATING CANCERS | CULLGEN (SHANGHAI) , INC. (CN) | 2020-10-08 | — | — | WO | disclosed |
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |